(19)
(11) EP 3 768 707 A1

(12)

(43) Date of publication:
27.01.2021 Bulletin 2021/04

(21) Application number: 19771532.9

(22) Date of filing: 15.03.2019
(51) International Patent Classification (IPC): 
C07K 16/18(2006.01)
A61K 39/00(2006.01)
C07K 16/00(2006.01)
(86) International application number:
PCT/US2019/022572
(87) International publication number:
WO 2019/182910 (26.09.2019 Gazette 2019/39)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(30) Priority: 19.03.2018 US 201815924898

(71) Applicant: Kota Biotherapeutics, LLC
Bellevue, Washington 98005-4046 (US)

(72) Inventors:
  • HYDE, Roderick A.
    Redmond, Washington 98052 (US)
  • KINDSVOGEL, Wayne R.
    Seattle, Washington 98115 (US)
  • MCKNIGHT, Gary L.
    Bothell, Washington 98011 (US)

(74) Representative: D Young & Co LLP 
120 Holborn
London EC1N 2DY
London EC1N 2DY (GB)

   


(54) COMPOSITIONS AND METHODS FOR MODIFIED B CELLS EXPRESSING REASSIGNED BIOLOGICAL AGENTS